Mangalam Drugs & Organics (NSE:MANGALAM) EV-to-Revenue : 0.68 (As of Jul. 05, 2025)

Mangalam Drugs & Organics EV-to-Revenue Chart

Mangalam Drugs & Organics Annual Data
	Trend	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24	Mar25
EV-to-Revenue		Get a 7-Day Free Trial					0.60	0.56	-	0.69	0.63

Mangalam Drugs & Organics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-Revenue	Get a 7-Day Free Trial															0.69	0.37	0.76	0.53	0.63

Competitive Comparison of Mangalam Drugs & Organics's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mangalam Drugs & Organics's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mangalam Drugs & Organics's EV-to-Revenue falls into.

Mangalam Drugs & Organics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Mangalam Drugs & Organics's EV-to-Revenue for today is calculated as:

Mangalam Drugs & Organics's current Enterprise Value is ₹2,162 Mil.
Mangalam Drugs & Organics's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,176 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mangalam Drugs & Organics  (NSE:MANGALAM) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Mangalam Drugs & Organics's PS Ratiofor today is calculated as:

Mangalam Drugs & Organics's share price for today is ₹84.84.
Mangalam Drugs & Organics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹200.69.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mangalam Drugs & Organics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangalam Drugs & Organics Business Description